Delaware
|
001-37568
|
26-4231384
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
300 Connell Drive, Suite 4000
Berkeley Heights, NJ
|
07922
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02 |
Results of Operations and Financial Condition
|
Item 9.01. |
Financial Statements and Exhibits
|
Exhibit
Number
|
Description
|
99.1
|
Press release dated February 21, 2019 announcing financial results for the full-year ended December 31, 2018.
|
Dated: February 21, 2019
|
Edge Therapeutics, Inc.
|
By:
|
/s/ Andrew Saik | |
|
Name: Andrew Saik
|
|
|
Title: Chief Financial Officer
|
Exhibit
Number
|
Description |
|
|
99.1 |
Press release dated February 21, 2019 announcing financial results for the full-year ended December 31, 2018. |